{
     "PMID": "19615365",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20090929",
     "LR": "20161122",
     "IS": "1090-2430 (Electronic) 0014-4886 (Linking)",
     "VI": "219",
     "IP": "2",
     "DP": "2009 Oct",
     "TI": "Attenuated neurotoxicity of the transactivation-defective HIV-1 Tat protein in hippocampal cell cultures.",
     "PG": "586-90",
     "LID": "10.1016/j.expneurol.2009.07.005 [doi]",
     "AB": "This study reports that the cysteine 22-->glycine 22 substitution in the HIV-1 Tat 1-86 B significantly attenuates its neurotoxicity. Consistent with previous studies, direct interactions of rat hippocampal cells with Tat 1-86 B were shown to cause dose-dependent and time-dependent neurotoxicity associated with activation of caspases from the mitochondrial apoptotic pathway. Despite the similar binding/uptake properties, Cys22 Tat 1-86 B failed to induce significant neurotoxicity and activation of caspases 9 and 3/7 in hippocampal primary cultures. Results of the study underscore the important role of cysteine-rich domain in mechanism of Tat-mediated neurotoxicity.",
     "FAU": [
          "Aksenov, Michael Y",
          "Aksenova, Marina V",
          "Mactutus, Charles F",
          "Booze, Rosemarie M"
     ],
     "AU": [
          "Aksenov MY",
          "Aksenova MV",
          "Mactutus CF",
          "Booze RM"
     ],
     "AD": "Program in Behavioral Neuroscience, University of South Carolina, SC 25908, USA. aksenov@mailbox.sc.edu",
     "LA": [
          "eng"
     ],
     "GR": [
          "R01 DA009160-07/DA/NIDA NIH HHS/United States",
          "HD 43680/HD/NICHD NIH HHS/United States",
          "R01 HD043680-04/HD/NICHD NIH HHS/United States",
          "R01 DA011337-03/DA/NIDA NIH HHS/United States",
          "R01 HD043680/HD/NICHD NIH HHS/United States",
          "R03 DA031604/DA/NIDA NIH HHS/United States",
          "DA 11337/DA/NIDA NIH HHS/United States",
          "DA 13137/DA/NIDA NIH HHS/United States",
          "DA 09160/DA/NIDA NIH HHS/United States",
          "R01 DA009160/DA/NIDA NIH HHS/United States",
          "R01 DA011337/DA/NIDA NIH HHS/United States",
          "R01 DA013137/DA/NIDA NIH HHS/United States",
          "R01 DA013137-10/DA/NIDA NIH HHS/United States"
     ],
     "PT": [
          "Journal Article",
          "Research Support, N.I.H., Extramural"
     ],
     "DEP": "20090715",
     "PL": "United States",
     "TA": "Exp Neurol",
     "JT": "Experimental neurology",
     "JID": "0370712",
     "RN": [
          "0 (Gene Products, tat)",
          "0 (tat Gene Products, Human Immunodeficiency Virus)",
          "EC 3.4.22.- (Caspases)",
          "K848JZ4886 (Cysteine)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Animals, Newborn",
          "Apoptosis/drug effects",
          "Caspases/metabolism",
          "Cells, Cultured",
          "Cysteine/genetics",
          "Dose-Response Relationship, Drug",
          "Gene Products, tat",
          "Hippocampus/*cytology",
          "Humans",
          "Neurons/*drug effects",
          "Rats",
          "Rats, Sprague-Dawley",
          "Transcriptional Activation/*physiology",
          "tat Gene Products, Human Immunodeficiency Virus/genetics/metabolism/*pharmacology"
     ],
     "PMC": "PMC2770879",
     "MID": [
          "NIHMS138989"
     ],
     "EDAT": "2009/07/21 09:00",
     "MHDA": "2009/09/30 06:00",
     "CRDT": [
          "2009/07/21 09:00"
     ],
     "PHST": [
          "2009/05/01 00:00 [received]",
          "2009/06/10 00:00 [revised]",
          "2009/07/06 00:00 [accepted]",
          "2009/07/21 09:00 [entrez]",
          "2009/07/21 09:00 [pubmed]",
          "2009/09/30 06:00 [medline]"
     ],
     "AID": [
          "S0014-4886(09)00271-4 [pii]",
          "10.1016/j.expneurol.2009.07.005 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Exp Neurol. 2009 Oct;219(2):586-90. doi: 10.1016/j.expneurol.2009.07.005. Epub 2009 Jul 15.",
     "term": "hippocampus"
}